SC
ABEO icon

Shay Capital’s Abeona Therapeutics ABEO Stock Holding History

Shay Capital’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,000
Closed -$10K – 346
2022
Q2 		$10K Hold
2,000
– – ﹤0.01% 401
2022
Q1 		$16K Hold
2,000
– – ﹤0.01% 479
2021
Q4 		$17K Buy
+2,000
New +$36.7K ﹤0.01% 460

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Shay Capital's ABEO Position: Q3 2022 in Review

Shay Capital sold out of Abeona Therapeutics (ABEO) in Q3 2022, closing a stake of 2,000 shares — an estimated $10K sold.

Shay Capital first reported a position in ABEO in Q4 2021 and held it in 3 quarters. The position peaked at $17K in Q4 2021. 24 funds tracked by Wall St. Rank hold ABEO as of Q3 2022.

  • Shay Capital reported no remaining Abeona Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Shay Capital sold 2,000 Abeona Therapeutics shares in Q3 2022, an estimated $10K.
  • Shay Capital first reported a position in Abeona Therapeutics in Q4 2021 and held it in 3 quarters.
  • Shay Capital's Abeona Therapeutics position peaked at $17K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2022.

Based on Shay Capital's 13F filing for Q3 2022, filed 14 Nov 2022.